INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, vol.24, no.2, pp.254-259, 2021 (Journal Indexed in SCI)
Article / Article
Title of Journal :
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
antirheumatic therapy, anti‐, tumor necrosis factor therapy, hepatitis B, hepatitis B virus reactivation, hepatitis B virus screening, VIRUS HBV REACTIVATION, OCCULT CARRIERS, PREVENTION, GUIDELINES, SAFETY
Objective The purpose of this study was to determine hepatitis B virus (HBV) screening rates in patients receiving anti-tumor necrosis factor (TNF)-alpha therapy and the frequency of HBV reactivation in patients with resolved hepatitis B virus infection (hepatitis B surface antigen [HBsAg] negative, hepatitis B core antibody [Anti-HBc] positive).